E34.3
Short stature due to endocrine disorder
Clinical Classification Guidelines
Excludes Type 1
- achondroplastic short stature (Q77.4)
- hypochondroplastic short stature (Q77.4)
- nutritional short stature (E45)
- pituitary short stature (E23.0)
- progeria (E34.8)
- renal short stature (N25.0)
- Russell-Silver syndrome (Q87.19)
- short-limbed stature with immunodeficiency (D82.2)
- short stature (child) (R62.52)
- short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
- short stature NOS (R62.52)
Medical Intelligence & Overview
Short stature due to endocrine disorder, classified under ICD-10 code E34.3, refers to a condition where a person is significantly shorter than average for their age and sex, caused by issues related to hormone production or functioning. This condition can affect growth during childhood and adolescence, potentially leading to a shorter adult height. The underlying endocrine problems often involve hormones that regulate growth and development, such as growth hormone, thyroid hormones, or sex steroids. Recognizing and understanding this condition helps in seeking appropriate diagnosis and management to support healthy growth.
Causes & Symptoms
Clinical Causes: Growth hormone deficiency: A common cause where the body does not produce enough growth hormone needed for normal growth. Hypothyroidism: Low levels of thyroid hormones can impair growth and development. Pituitary gland disorders: Conditions affecting the pituitary gland can disrupt hormone production essential for growth. Congenital conditions: Genetic syndromes like Turner syndrome or Noonan syndrome that affect growth pathways. Chronic illnesses: Long-term illnesses such as kidney disease or gastrointestinal disorders that impact growth. Nutritional deficiencies: Inadequate nutrition during critical growth periods can lead to stunted growth. Other hormonal imbalances: Disorders affecting sex steroids or adrenal hormones that influence growth and maturation.
Key Symptoms: Markedly short stature compared to peers. Delayed growth milestones or puberty. Normal body proportions, or occasionally disproportionate features depending on the underlying condition. Delayed or absent secondary sexual characteristics. Potential signs of associated syndromes or health issues, such as facial features or organ anomalies.
Diagnostic & Treatment
Diagnosis Path: Growth assessment charts to compare height over time. Blood tests to measure hormone levels, including growth hormone, thyroid function tests, and sex hormones. Imaging studies like X-rays of the hand and wrist to assess bone age. Genetic testing if a congenital syndrome is suspected. Evaluations for underlying chronic illnesses contributing to growth impairment.
Treatment Protocols: Hormone therapy: Such as growth hormone injections for deficiency cases. Managing associated conditions: Treating thyroid imbalances or other hormonal disorders. Nutritional support: Ensuring adequate diet to promote healthy growth. Monitoring growth and development regularly to adjust treatment plans. Psychological support: Addressing emotional or social challenges related to short stature.
Clinical Advice & FAQs
Billing Guidance
Is E34.3 a billable ICD-10 code?
Yes, E34.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E34.3?
Clinical documentation must specify the nature of Short stature due to endocrine disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference